Headlines
UK pledges extra $2 billion NHS spend to avert Trump tariffs, FT says
Published by Global Banking & Finance Review®
Posted on December 11, 2025
1 min readLast updated: January 20, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on December 11, 2025
1 min readLast updated: January 20, 2026
The UK has pledged an additional $2 billion for NHS medicines over three years to avoid US tariffs. This move aims to increase NHS spending to 0.35% of GDP by 2028.
Dec 11 (Reuters) - Britain has promised the United States that spending on National Health Service (NHS) medicines will rise by 1.5 billion pounds ($2 billion) over the next three years, the Financial Times said on Thursday.
The pledge is part of a deal to win exemption from drug import levies threatened by U.S. President Donald Trump, that aims to boost such spending to 0.35% of GDP from 0.3% by the end of 2028, the paper said, citing people familiar with the deal.
Reuters could not immediately verify the report.
($1=0.7482 pounds)
(Reporting by Mrinmay Dey in Bengaluru; Editing by Clarence Fernandez)
The main topic is the UK's pledge to increase NHS spending to avoid US tariffs on drug imports.
The UK has committed to increasing NHS medicine spending by $2 billion over the next three years.
The goal is to boost NHS spending to 0.35% of GDP by 2028 and avoid US drug import levies.
Explore more articles in the Headlines category
